Biotech Values

[iwfal]

To repeat the results, the Alexion trial was in fact statistically significant in reducing non fatal mi and did not reduce death in 30 days which you said it doesnt have to do.

Not exactly fair - Alexion's PRIMO-CABG did show a meaningful reduction in death, but the total number of events was too low. FWIW.

Clark